Mixed Hormone Receptor (ER+/PR- Or ER-/PR+) Breast Cancer

By A Mystery Man Writer

Detailed information on mixed hormone receptor (ER+/PR- or ER-/PR+) breast cancer prognosis, based on the latest scientific studies.

Mechanisms and therapeutic advances in the management of endocrine-resistant breast cancer

Estrogen receptor signaling regulates the expression of the breast tumor kinase in breast cancer cells, BMC Cancer

The impact of histologic subtype on primary site surgery in the management of metastatic lobular versus ductal breast cancer: a population based study from the National Cancer Database (NCDB)

AR, PSA, ER/PR, HER2/neu immunoexpression in breast carcinomas

ER+/PR+ Breast Cancer Characteristics

Clinically-relevant models reveal new insights into patient heterogeneity and hormone action in estrogen receptor positive (ER+) breast cancer.

In modern times, how important are breast cancer stage, grade and receptor subtype for survival: a population-based cohort study, Breast Cancer Research

Breast Cancer and Hormone Receptor Positive Status - Moose and Doc

Estrogen receptor-negative/progesterone receptor-positive and her-2-negative breast cancer might no longer be classified as hormone receptor-positive breast cancer

The challenges of modeling hormone receptor-positive breast cancer in mice in: Endocrine-Related Cancer Volume 25 Issue 5 (2018)

Frontiers Characteristics and survival in bone metastatic breast cancer patients with different hormone receptor status: A population-based cohort study

ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation